The Patent Finder

Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof

Apellis Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2012/037648, filed May 11, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,001,610Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
In force
 · High confidence
UsedRemaining
Apellis Pharmaceuticals, Inc.In forceHigh confidence
US 11,661,441Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
In force
 · High confidence
Apellis Pharmaceuticals, Inc.In forceHigh confidence
US 10,125,171Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
In force
 · High confidence
Apellis Pharmaceuticals, Inc.In forceHigh confidence
Application 18/133,372Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Abandoned
Abandoned Sep 29, 2025
Apellis Pharmaceuticals, Inc.AbandonedAbandoned Sep 29, 2025
Application 19/197,537Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Pending
Not granted
Apellis Pharmaceuticals, Inc.PendingNot granted
Application 19/229,679Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Pending
Not granted
Apellis Pharmaceuticals, Inc.PendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Apellis Pharmaceuticals, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited